Salivary gland function std
CPT 78232 covers a nuclear medicine test that measures how well your salivary glands produce and release saliva, using a small amount of radioactive tracer to create images and track gland function over time.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Document both the imaging component AND quantitative functional analysis with secretory stimulation (typically lemon juice or citric acid) to support CPT 78232 rather than simple imaging code
Impact: Prevents downcoding to lower-paying imaging-only codes; maintains full $99.30 reimbursement versus potential denial
Ensure documentation specifies bilateral imaging even if only one gland is symptomatic, as standard protocol images both sides for comparison
Impact: Supports medical necessity and prevents payer challenges requesting additional imaging studies separately
Bill with appropriate ICD-10 codes documenting specific indication (K11.7 for xerostomia, M35.0- for Sjögren's) rather than vague symptoms
Impact: Reduces medical necessity denials by 35-40% and supports coverage determination
When performed in split/shared arrangements, clearly document which provider performed technical supervision versus interpretation to support correct modifier usage
Impact: Prevents claim rejections for modifier errors and ensures correct revenue distribution between facility and professional fees
Verify payer-specific prior authorization requirements, as many commercial payers require pre-certification for nuclear medicine studies
Impact: Prevents 100% payment denial; prior authorization denial rates for nuclear medicine average 15-20% when not obtained
Report radiopharmaceutical separately using HCPCS code A9512 (Tc-99m pertechnetate) when billing in non-facility settings where drug cost is not bundled
Recovers additional $25-45 in radiopharmaceutical costs that would otherwise be absorbed as practice expense
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.